Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Cassava Insiders Got A Lot Richer As Shares Rebound Following Refutation of Data Manipulation Claims

By Vandana Singh
August 18, 1:06 PM
Journal of Prevention of Alzheimer’s Disease (JPAD) informed Cassava Sciences Inc (NASDAQ:SAVA) about no convincing evidence to support data manipulation allegations…

SAVA

Read More
2 minute read
  • Entertainment
  • General
  • News
  • Small Cap

Spotify Wants You To Buy Concert Tickets While You’re Listening To Music

By Chris Katje
August 18, 1:01 PM
Music streaming service Spotify Technology NA (NYSE: SPOT) could have a new source of revenue and customer acquisition. Here’s a look at how the company could be disrupting the ticketing space.

EB

Read More
4 minute read
  • Entertainment
  • Gaming
  • General
  • News
  • Trading Ideas

My Precious, You Shall Now Pass: Lord of The Rings’ Gollum, Gandalf May Get Their Own Movies

By Chris Katje
August 18, 12:46 PM
Video game company Embracer Group AB (OTC: THQQF) is purchasing several rights to The Lord of the Rings and The Hobbit franchises that could bring theme parks and more movies to fans of the J.R.R. Tolkien books.

AMZN

Read More
1 minute read
  • Earnings
  • General
  • News

Melco Resorts Posts 47% Revenue Decline In Q2 Battered By COVID-19 Curbs In China And Macau

By Shivani Kumaresan
August 18, 12:43 PM
Melco Resorts & Entertainment Ltd (NASDAQ:MLCO) reported a second-quarter FY22 sales decline of 48% year-on-year to $296.11 million, versus…

MLCO

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Novavax’s Covid-19 Vaccine Cleared For Use In New Zealanders Aged 12-17

By Vandana Singh
August 18, 12:18 PM
New Zealand’s Medsafe has granted expanded provisional approval for Novavax Inc’s (NASDAQ:NVAX) Nuvaxovid (NVX-CoV2373) COVID-19 vaccine in adolescents aged 12 through 17.…

NVAX

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Fighting Omicron: This Covid Vaccine Candidate Is Going After The Dangerous Mutation

By Vandana Singh
August 18, 12:12 PM
CureVac N.V.  (NASDAQ:CVAC) and GSK plc (NYSE:GSK) have started a Phase 1 trial of the modified COVID-19 mRNA vaccine candidate, administered as a…

CVAC

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

China-Based Jemincare Inks Prostate Cancer Drug Pact With Roche’s Genentech

By Vandana Singh
August 18, 12:07 PM
After penning a deal with Orion in May for a non-opioid pain drug, Jemincare is back at the…

RHHBF

Read More
1 minute read
  • General
  • News
  • Politics

Asian Development Bank To Consider Ending New Loans To China; Adb Plans To Provide China With Up To $7.5B In Financing From 2021 To 2025, Down From $9B Between 2016 And 2020

By Benzinga Newsdesk
August 18, 12:06 PM
-Nikkei Report

FXI

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News

Astellas’ Menopause Drug Under FDA Review

By Vandana Singh
August 18, 12:04 PM
The FDA accepted Astellas Pharma Inc’s (OTC:ALPMF) menopause treatment for approval five months after the therapy hit a speed bump in…

ALPMF

Read More
1 minute read
  • FDA
  • General
  • News
  • Politics

Biden Administration Expects Months Of Talks To End Federal Coverage For Covid-19 Shots, Treatments

By Benzinga Newsdesk
August 18, 12:04 PM
-Reuters

SPY

Posts pagination

Previous 1 … 2,218 2,219 2,220 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service